Picture of Zylox-Tonbridge Medical Technology Co logo

2190 Zylox-Tonbridge Medical Technology Co Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Annual cashflow statement for Zylox-Tonbridge Medical Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M
Source:PROSPECTUSPROSPECTUSARS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinal
Net Income/Starting Line-66.6-100-200
Depreciation
Amortisation
Non-Cash Items5.7422.455.9
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.75-13.914.2
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-53.1-82.3-116
Capital Expenditures-41.6-45.1-89.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-49-204-1,239
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-90.6-249-1,328
Financing Cash Flow Items179336399
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1793462,810
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash35.613.41,359

Or unlock with your email

Or unlock with your email